Keyphrases
Acute Myeloid Leukemia
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
35%
Breast Cancer
41%
Breast Cancer Diagnosis
27%
Breast Reconstruction
17%
Chemotherapy
33%
Clinical Trials
21%
Comorbidity
17%
Computed Tomographic Colonography
39%
Confidence Interval
28%
Cost-effectiveness
68%
Cost-effectiveness Analysis
32%
COVID-19
19%
Distant Recurrence
16%
Drug Costs
22%
Economic Evaluation
20%
Employer-sponsored Health Insurance
20%
Employment Insurance
15%
Extracolonic Findings
20%
Families with children
15%
Health Care Costs
17%
Health Insurance
19%
Health Outcomes Research
16%
Health Status
15%
Healthcare
23%
Healthcare Utilization
24%
Hematopoietic Cell Transplantation
26%
Hip Fracture
15%
Hospitalist
20%
Incremental Cost-effectiveness Ratio
15%
Intervention Optimization
19%
Length of Stay
20%
Liver Transplant Recipients
20%
Liver Transplantation
17%
Lobectomy
31%
Locally Advanced Breast Cancer
24%
Locoregional Recurrence
20%
Magnetic Resonance Imaging
19%
Medical Care
15%
Meta-analysis
20%
Microsimulation
20%
Multiphase Optimization Strategy
41%
Odds Ratio
27%
Osteoporosis
20%
Pembrolizumab
20%
Quality-adjusted Life Years
32%
Randomized Controlled Trial
19%
Surgeons
15%
Surveillance Imaging
20%
United States
60%
Medicine and Dentistry
Acute Myeloid Leukemia
25%
Artificial Respiration
11%
Base
11%
Behavioral Change
10%
Breast Cancer
68%
Cancer Diagnosis
22%
Cancer Therapy
11%
Cell Transplantation
50%
Checklist
20%
Clinical Trial
11%
Colonoscopy
16%
Computer Assisted Tomography
21%
Cost-Effectiveness Analysis
50%
Diagnosis
12%
Diseases
13%
Emergency Care
15%
Emergency Department
16%
Genetic Screening
10%
Health Care
24%
Health Care Cost
100%
Health Outcomes
13%
Ischemic Heart Disease
10%
Lobectomy
31%
Logistic Regression Analysis
10%
Magnetic Resonance Imaging
46%
Malignant Neoplasm
26%
Mass Screening
10%
Maximum Likelihood Method
15%
Medicare
31%
Meta-Analysis
20%
Outpatient
22%
Papillary Thyroid Cancer
10%
Placebo
10%
Prevalence
27%
Quality Adjusted Life Year
12%
Randomized Controlled Trial
15%
Rating Scale
10%
Receptor
10%
Recurrence Risk
12%
Recurrent Disease
31%
Statin
10%
Subacute Care
13%
Surgeon
15%
Systematic Review
31%
Thyroid Nodule
10%
Thyroidectomy
10%
Thyrotropin
10%
Thyroxine
10%
Virtual Colonoscopy
41%
